CLIP2 as radiation biomarker in papillary thyroid carcinoma

被引:40
|
作者
Selmansberger, M. [1 ]
Feuchtinger, A. [2 ]
Zurnadzhy, L. [3 ]
Michna, A. [1 ]
Kaiser, J. C. [4 ]
Abend, M. [5 ]
Brenner, A. [6 ]
Bogdanova, T. [3 ]
Walch, A. [2 ]
Unger, K. [1 ,7 ]
Zitzelsberger, H. [1 ,7 ]
Hess, J. [1 ,7 ]
机构
[1] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, D-85764 Neuherberg, Germany
[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany
[3] Natl Acad Med Sci Ukraine, Inst Endocrinol & Metab, Kiev, Ukraine
[4] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany
[5] Bundeswehr Inst Radiobiol, Munich, Germany
[6] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[7] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, D-85764 Neuherberg, Germany
关键词
INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; CHERNOBYL ACCIDENT; CANCER; PROTEIN; REARRANGEMENTS; EXPOSURE; KINESIN; RET/PTC; DYNEIN;
D O I
10.1038/onc.2014.311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A substantial increase in papillary thyroid carcinoma (PTC) among children exposed to the radioiodine fallout has been one of the main consequences of the Chernobyl reactor accident. Recently, the investigation of PTCs from a cohort of young patients exposed to the post-Chernobyl radioiodine fallout at very young age and a matched nonexposed control group revealed a radiation-specific DNA copy number gain on chromosomal band 7q11.23 and the radiation-associated mRNA overexpression of CLIP2. In this study, we investigated the potential role of CLIP2 as a radiation marker to be used for the individual classification of PTCs into CLIP2-positive and - negative cases-a prerequisite for the integration of CLIP2 into epidemiological modelling of the risk of radiation-induced PTC. We were able to validate the radiation-associated CLIP2 overexpression at the protein level by immunohistochemistry (IHC) followed by relative quantification using digital image analysis software (P = 0.0149). Furthermore, we developed a standardized workflow for the determination of CLIP2-positive and - negative cases that combines visual CLIP2 IHC scoring and CLIP2 genomic copy number status. In addition to the discovery cohort (n = 33), two independent validation cohorts of PTCs (n = 115) were investigated. High sensitivity and specificity rates for all three investigated cohorts were obtained, demonstrating robustness of the developed workflow. To analyse the function of CLIP2 in radiation-associated PTC, the CLIP2 gene regulatory network was reconstructed using global mRNA expression data from PTC patient samples. The genes comprising the first neighbourhood of CLIP2 (BAG2, CHST3, KIF3C, NEURL1, PPIL3 and RGS4) suggest the involvement of CLIP2 in the fundamental carcinogenic processes including apoptosis, mitogen-activated protein kinase signalling and genomic instability. In our study, we successfully developed and independently validated a workflow for the typing of PTC clinical samples into CLIP2-positive and CLIP2-negative and provided first insights into the CLIP2 interactome in the context of radiation-associated PTC.
引用
收藏
页码:3917 / 3925
页数:9
相关论文
共 50 条
  • [1] CLIP2 as radiation biomarker in papillary thyroid carcinoma
    Selmansberger, M.
    Feuchtinger, A.
    Zurnadzhy, L.
    Hoefig, I.
    Bogdanova, T.
    Walch, A.
    Unger, K.
    Zitzelsberger, H.
    Hess, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S113 - S113
  • [2] CLIP2 as radiation biomarker in papillary thyroid carcinoma
    M Selmansberger
    A Feuchtinger
    L Zurnadzhy
    A Michna
    J C Kaiser
    M Abend
    A Brenner
    T Bogdanova
    A Walch
    K Unger
    H Zitzelsberger
    J Hess
    Oncogene, 2015, 34 : 3917 - 3925
  • [3] Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2
    Selmansberger, Martin
    Michna, Agata
    Braselmann, Herbert
    Hofig, Ines
    Schorpp, Kenji
    Weber, Peter
    Anastasov, Natasa
    Zitzelsberger, Horst
    Hess, Julia
    Unger, Kristian
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [4] Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2
    Martin Selmansberger
    Agata Michna
    Herbert Braselmann
    Ines Höfig
    Kenji Schorpp
    Peter Weber
    Natasa Anastasov
    Horst Zitzelsberger
    Julia Hess
    Kristian Unger
    Radiation Oncology, 15
  • [5] Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas
    Selmansberger, Martin
    Kaiser, Jan Christian
    Hess, Julia
    Guethlin, Denise
    Likhtarev, I.
    Shpak, Victor
    Tronko, Mykola
    Brenner, Alina
    Abend, Michael
    Blettner, Maria
    Unger, Kristian
    Jacob, Peter
    Zitzelsberger, Horst
    CARCINOGENESIS, 2015, 36 (07) : 748 - 756
  • [6] HSATII as a Biomarker of Papillary Thyroid Carcinoma
    Deshpande, A.
    Tan, J. N. M.
    Arora, K.
    Deshpande, V.
    Ting, D.
    De Las Morenas, A.
    MODERN PATHOLOGY, 2014, 27 : 100A - 100A
  • [7] HSATII as a Biomarker of Papillary Thyroid Carcinoma
    Deshpande, A.
    Tan, J. N. M.
    Arora, K.
    Deshpande, V.
    Ting, D.
    De Las Morenas, A.
    LABORATORY INVESTIGATION, 2014, 94 : 100A - 100A
  • [8] Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
    Wang, Zhiyang
    Li, Jing
    Liu, Ziwei
    Yue, Ling
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2023, 67 (02):
  • [9] Molecular classification and biomarker discovery in papillary thyroid carcinoma
    Sheils, O
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (06) : 927 - 946
  • [10] Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma
    Tabur, S.
    Korkmaz, H.
    Ozkaya, M.
    Elboga, U.
    Tarakcioglu, M.
    Aksoy, N.
    Akarsu, E.
    TUMOR BIOLOGY, 2015, 36 (10) : 7549 - 7556